AFM
VIVE

Anson Funds Management’s VIVEVE MED INC VIVE Stock Holding History

Anson Funds Management’s Portfolio VIVE Stock Details VIVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-250
Closed -$263K – 61
2018
Q4 		$263K Buy
+250
New +$600K 0.15% 36

Other funds holding VIVE

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

Anson Funds Management's VIVE Position: Q1 2019 in Review

Anson Funds Management sold out of VIVEVE MED INC (VIVE) in Q1 2019, closing a stake of 250 shares — an estimated $263K sold.

Anson Funds Management first reported a position in VIVE in Q4 2018 and held it in 1 quarter. The position peaked at $263K in Q4 2018. 30 funds tracked by Wall St. Rank hold VIVE as of Q1 2019.

  • Anson Funds Management reported no remaining VIVEVE MED INC position as of Q1 2019 after selling out during the quarter.
  • Anson Funds Management sold 250 VIVEVE MED INC shares in Q1 2019, an estimated $263K.
  • Anson Funds Management first reported a position in VIVEVE MED INC in Q4 2018 and held it in 1 quarter.
  • Anson Funds Management's VIVEVE MED INC position peaked at $263K in Q4 2018.
  • 30 funds tracked by Wall St. Rank held VIVEVE MED INC as of Q1 2019.

Based on Anson Funds Management's 13F filing for Q1 2019, filed 15 May 2019.